Consumo de ciprofloxacino 200 mg/100 mL en pacientes hospitalizados del Hospital II Chocope – EsSalud, Abril 2019 - marzo 2020
| dc.contributor.advisor | Polo Bardales, José Luis | |
| dc.contributor.author | Mantilla Vasquez, Liliana | |
| dc.date.accessioned | 2023-11-16T12:23:34Z | |
| dc.date.available | 2023-11-16T12:23:34Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | El objetivo que tuvo este presente informe de prácticas pre-profesionales fue determinar el consumo de ciprofloxacino 200 mg/100 mL en pacientes hospitalizados del Hospital II Chocope – EsSalud, abril 2019- marzo 2020 en los servicios de hospitalización (Medicina, Cirugía, Ginecología, Obstetricia, Unidad de Vigilancia Intensiva - Uvi). Para lo cual se desarrolló un estudio tipo descriptivo - retrospectivo. Para determinar el consumo de ciprofloxacino 200 mg/100 mL administrados por vía endovenosa se utilizó la metodología del sistema de Dosis Diaria Definida (DDD), los datos fueron obtenidos del Sistema de Gestión Hospitalaria del Hospital II-Chocope. El mayor consumo ciprofloxacino 200 mg/100 mL fue en el mes de abril con un total de 383 unidades consumidas lo cual representa el 13% y los meses de menos consumo fueron noviembre con un total de 143 unidades consumidas lo cual representa el 5% y marzo con un total de 143 unidades consumidas lo cual representa el 5%. Con respecto al consumo mensual de ciprofloxacino 200 mg/100 mL expresado en DDD/100 camas/día, se obtuvo como resultado que la DDD/100 camas/día más alto fue en el mes de abril con un valor de 9,01 y el DDD/100 camas/día más bajo fue en el mes de marzo. La tendencia de la DDD/100 camas/día de ciprofloxacino 200 mg/100 mL presento un coeficiente de correlación positivo r=0,81 con un nivel de significancia p=0,44 el cual es estadísticamente no significativo. Finalmente se evaluó el costo total del consumo de ciprofloxacino 200 mg/100 mL durante el periodo de abril 2019- marzo 2020 generando un costo total de S/. 3591,42. | |
| dc.description.abstract | ABSTRACT The objective of this report of pre-professional practices was to determine the consumption of ciprofloxacin 200 mg/100 mL in hospitalized patients of hospital II Chocope – EsSalud, April 2019- March 2020 in hospitalization services (Medicine, Surgery, Gynecology, Obstetrics, Intensive Surveillance Unit-Uvi). For which a descriptive-retrospective study was developed. To determine the consumption of ciprofloxacin 200 mg/100 mL administered intravenously, the methodology of the Defined Daily Dose (DDD) system was used, the data were obtained from the Hospital Management System of the II-Chocope Hospital. The highest consumption ciprofloxacin 200 mg / 100 mL was in the month of April with a total of 383 units consumed which represents 13% and the months of least consumption were November with a total of 143 units consumed which represents 5% and March with a total of 143 units consumed which represents 5%. With respect to the monthly consumption of ciprofloxacin 200 mg/100 mL expressed in DDD/100 beds/day, it was obtained as a result that the highest DDD/100 beds/day was in the month of April with a value of 9.01 and the lowest DDD/100 beds/day was in the month of March. The DDD/100 bed/day trend of ciprofloxacin 200 mg/100 mL presented a positive correlation coefficient r=0.81 with a level of significance p=0.44 which is statistically non-significant. Finally, the total cost of the consumption of ciprofloxacin 200 mg/100 mL during the period of April 2019- March 2020 was evaluated, generating a total cost of S/. 3 591.42. | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14414/19617 | |
| dc.language.iso | spa | |
| dc.publisher | Universidad Nacional de Trujillo | |
| dc.publisher.country | PE | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.source | Universidad Nacional de Trujillo | |
| dc.source | Repositorio Institucional UNITRU | |
| dc.subject | Antibióticos | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.05 | |
| dc.title | Consumo de ciprofloxacino 200 mg/100 mL en pacientes hospitalizados del Hospital II Chocope – EsSalud, Abril 2019 - marzo 2020 | |
| dc.type | info:eu-repo/semantics/bachelorThesis | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| renati.advisor.dni | 18099068 | |
| renati.advisor.orcid | https://orcid.org/0000-0002-4628-0568 | |
| renati.author.dni | 46605329 | |
| renati.discipline | 917046 | |
| renati.juror | Chávez Abanto, Luis Alberto | |
| renati.juror | Polo Bardales, José Luis | |
| renati.juror | Gutiérrez Mendoza, Danny daniel | |
| renati.level | http://purl.org/pe-repo/renati/level#tituloProfesional | |
| renati.type | http://purl.org/pe-repo/renati/type#tesis | |
| thesis.degree.discipline | Farmacia | |
| thesis.degree.grantor | Universidad Nacional de Trujillo. Facultad de Farmacia y Bioquímica | |
| thesis.degree.name | Químico Farmacéutico |